It is a pharma private limited company based in Visakhapatnam, Andhra Pradesh, India, established in 2014.
2014 | Visakhapatnam, Andhra Pradesh, India | ActiveSatya Kalyan Pharmaceuticals Private Limited, a active private limited company, was established on 22 August 2014 in Visakhapatnam, Andhra Pradesh, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U74110AP2014PTC095129. Registered under ROC Roc Vijayawada. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
Formerly known as Satya Kalyan Estates & Infrastructures Private Limited. It upholds a compliant status. Its leadership includes Murali Krishna Vankayalapati (Director), Kalyan Satyamani Vankayalapati (Director), Rajarajeswari Vankayalapati (Director). Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Sy. No. 127, Vemulavalasa Anandapuram Mandal, Visakhapatnam, Andhra Pradesh, 531163.
U74110AP2014PTC095129
095129
22 August 2014
₹0.10 M
₹0.10 M
Roc Vijayawada
Unlisted
Active
Explore comprehensive insights into Satya Kalyan Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Murali Krishna Vankayalapati | Director | 22 Aug 2014 | Current |
| Kalyan Satyamani Vankayalapati | Director | 22 Aug 2014 | Current |
| Rajarajeswari Vankayalapati | Director | 22 Aug 2014 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Satya Kalyan Pharmaceuticals Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Satya Kalyan Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Satya Kalyan Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Satya Kalyan Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Satya Kalyan Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Satya Kalyan Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Satya Kalyan Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Vijayawada. was recorded as a recent event.
Progress on Murali Krishna Vankayalapati was appointed as a Director was appointed as a Director on 22 Aug 2014 & has been associated with this company since 11 years 4 months . was documented.
The activity Kalyan Satyamani Vankayalapati was appointed as a Director was appointed as a Director on 22 Aug 2014 & has been associated with this company since 11 years 4 months . was completed.
Progress on Rajarajeswari Vankayalapati was appointed as a Director was appointed as a Director on 22 Aug 2014 & has been associated with this company since 11 years 4 months . was documented.
Progress on Satya Kalyan Pharmaceuticals Private Limited was registered on 22 Aug 2014 with Roc Vijayawada & aged 11 years 4 months as per MCA records. was documented.
The CIN of Satya Kalyan Pharmaceuticals Private Limited is U74110AP2014PTC095129.
Satya Kalyan Pharmaceuticals Private Limited is headquartered at Sy. No. 127, Vemulavalasa Anandapuram Mandal, Visakhapatnam, Andhra Pradesh, 531163.
Satya Kalyan Pharmaceuticals Private Limited was incorporated on 22 August 2014.
The current directors of Satya Kalyan Pharmaceuticals Private Limited are
The primary industry of Satya Kalyan Pharmaceuticals Private Limited is Trade.
Satya Kalyan Pharmaceuticals Private Limited is unlisted.
The authorized capital of Satya Kalyan Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Satya Kalyan Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX